| 000 | 01504 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250516034605.0 | ||
| 264 | 0 | _c20110922 | |
| 008 | 201109s 0 0 eng d | ||
| 022 | _a1476-6256 | ||
| 024 | 7 |
_a10.1093/aje/kwq493 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSchenk, Jeannette M | |
| 245 | 0 | 0 |
_aAssociation of symptomatic benign prostatic hyperplasia and prostate cancer: results from the prostate cancer prevention trial. _h[electronic resource] |
| 260 |
_bAmerican journal of epidemiology _cJun 2011 |
||
| 300 |
_a1419-28 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural | ||
| 650 | 0 | 4 |
_a5-alpha Reductase Inhibitors _xtherapeutic use |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 | _aCase-Control Studies |
| 650 | 0 | 4 |
_aFinasteride _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPrevalence |
| 650 | 0 | 4 |
_aProstatic Hyperplasia _xcomplications |
| 650 | 0 | 4 |
_aProstatic Neoplasms _xepidemiology |
| 650 | 0 | 4 | _aRisk Factors |
| 700 | 1 | _aKristal, Alan R | |
| 700 | 1 | _aArnold, Kathryn B | |
| 700 | 1 | _aTangen, Catherine M | |
| 700 | 1 | _aNeuhouser, Marian L | |
| 700 | 1 | _aLin, Daniel W | |
| 700 | 1 | _aWhite, Emily | |
| 700 | 1 | _aThompson, Ian M | |
| 773 | 0 |
_tAmerican journal of epidemiology _gvol. 173 _gno. 12 _gp. 1419-28 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/aje/kwq493 _zAvailable from publisher's website |
| 999 |
_c20804264 _d20804264 |
||